Related Experiment Video
Updated: Oct 3, 2026

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans
Published on: July 21, 2023
Relationship between elastin-derived peptides and the development of microvascular complications: a longitudinal
G Nicoloff1, S Baydanoff, N Stanimorova
1Department of Biology and Immunology, University School of Medicine, St. Kliment Ohridski Street No. 1, 5800, Pleven, Bulgaria. vmilibrpl@mbox.digsys.bg
Insights
Elastin-derived peptides (EDP) showed potential associations with microvascular complications in children with Type 1 diabetes. However, this pilot study suggests more research is needed to confirm EDP as an early predictor.
Area of Science:
- Biochemistry
- Endocrinology
- Pediatrics
Background:
- Type 1 diabetes mellitus (T1DM) is a chronic condition requiring long-term management.
- Microvascular complications are a significant concern in diabetic patients.
- Elastin-derived peptides (EDP) are potential biomarkers linked to vascular health.
Purpose of the Study:
- To investigate the association between elastin-derived peptides (EDP) and the development of microvascular complications in children with T1DM.
- To explore EDP as a potential early marker for diabetic microvascular complications.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to measure EDP levels in the sera of 28 children with T1DM.
- A longitudinal follow-up of 6 years was conducted.
- Control group comprised 24 healthy children of similar age and sex.
Main Results:
- Ten diabetic patients exhibited elevated EDP levels, with most having diabetes for over 5 years.
- Seven patients with increased EDP developed microvascular complications.
- EDP levels were independently associated with age, retinopathy, and antibodies to advanced glycation endproducts (AGEs).
Conclusions:
- This pilot study suggests a potential link between EDP and microvascular complications in pediatric T1DM.
- The current data are insufficient to establish EDP as a reliable predictor due to study limitations.
- Larger, longer prospective studies are required to validate the role of EDP as an early marker.
Abstract:
Levels of elastin-derived peptides (EDP) were determined by enzyme-linked immunosorbent assay (ELISA) in sera of 28 children with Type 1 (insulin-dependent) diabetes mellitus (mean age 11.6+/-2.8 years, diabetes duration 5.1+/-2.5 years). None of the children had clinical or laboratory evidence of vascular complications. The children were followed over a period of 6 years, and 24 healthy children of similar age and sex served as a control group. During the investigative period, 10 diabetic patients had increased EDP levels, with 9 having been diabetic for more than 5 years and 1 patient less than 5 years. Seven of these patients developed diabetic microvascular complications. In this group, EDP were independently associated with age (r=.39, P=.047), retinopathy (r=.48, P=.034), and antibodies to advanced glycation endproducts (AGE) (r=.52, P=.018). The data of this pilot study are not strong enough to appear that EDP are a useful predictor of subsequent development of microvascular complications. This may be due to the small number of subjects, short duration of the study, manner in which EDP or the endpoints were measured, or frequency of which EDP measurements were made. Further prospective and longer studies of larger populations are needed to identify the role of EDP as an early marker for the development of diabetic microvascular complications.
Related Concept Videos
Diabetic Retinopathy
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology
Type I Diabetes I: Introduction
Type I Diabetes III: Clinical Manifestations
